Literature DB >> 21284439

Field histology: Point-of-care microscopic technique.

Kaumakaokalani Calhoun1, Alexander Lin, Peter Bryant-Greenwood, Christopher Lum, Douglas Johnson, Thomas Namiki.   

Abstract

CONTEXT: Standard histology services in geographically remote areas are often not available or have long turn-around time, resulting in delayed diagnosis or inappropriate treatment due to incomplete diagnostic data. The use of rapid tissue processing and a portable microtome technique may offer timely, point-of-care histologic diagnosis to patients in a low resources setting, such as medical missions.
OBJECTIVE: To present an alternative to the conventional histologic processing that will permit point-of-care histopathology service.
DESIGN: A total of 21 tissue samples from a variety of sites were collected and subjected to a protocol of rapid manual tissue processing, lightweight portable field microtome sectioning, and hematoxylin-eosin staining. The histologic preparations were evaluated for diagnostic quality. The scoring of the preparations was based on completeness and uniformity of the sections, integrity of architectural features, cytologic detail, staining quality, and overall adequacy for diagnosis.
RESULTS: Diagnostic quality microscopic slides were obtained from each of the 21 samples that included lesions of the skin, uterus, colon, and breast. The average preparation time, including routine hematoxylin-eosin staining, was 1.5 hours.
CONCLUSIONS: We validated a point-of-care field histology technique that will be useful in settings of low resources, such as medical missions. Actual field testing of the procedure with special staining for fungi and acid-fast bacilli is the next step in the validation of the methodology.

Entities:  

Mesh:

Year:  2011        PMID: 21284439     DOI: 10.5858/135.2.207

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  2 in total

1.  Antigen dose and humoral immune response correspond with protection for inactivated infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L).

Authors:  Hetron Mweemba Munang'andu; Børge Nilsen Fredriksen; Stephen Mutoloki; Roy Ambli Dalmo; Øystein Evensen
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

2.  Immunogenicity and cross protective ability of the central VP2 amino acids of infectious pancreatic necrosis virus in Atlantic salmon (Salmo salar L.).

Authors:  Hetron M Munang'andu; Ane Sandtrø; Stephen Mutoloki; Bjørn E Brudeseth; Nina Santi; Øystein Evensen
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.